The report presents a detailed analysis of the diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on definition, epidemiology and etiology are reviewed.
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
List of Tables
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
List of Tables
- Major Companies Developing or Marketing Lymphogranuloma Tests
- France Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
- Germany Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
- Italy Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
- Japan Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
- Spain Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
- U.K. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
- U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
